Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

trial · primary record

Phentolamine Mesylate Ophthalmic Solution 1.0%

Night Vision Complaints

PhasePhase 2
StatusCOMPLETED
SponsorUnknown
Enrolment60
Primary completion2012-04-30
Primary endpointProportion of Eyes With ≥ 0.3 Log Increase in Mesopic Contrast Sensitivities for at Least 2 HACSS Frequencies
Registry IDNCT01703559

Provenance

  • Source: ClinicalTrials.gov
  • Fetched at: 2026-10-30T14:43:38.956Z
  • Licence class: attribution-required
  • Verdict: primary-source
  • Entity id: NCT01703559

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.